Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Wiesel

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Life Sciences|December 21, 1987
Decreased tyrosine transport in fibroblasts from schizophrenic patientsL Hagenfeldt, N Venizelos, L Bjerkenstedt, et al.
Psychopharmacology|January 1, 1989
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsL Farde, F A Wiesel, A L Nordström, et al.
Lancet (London, England)|January 5, 1980
Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophreniaA A Mathé, G Sedvall, F A Wiesel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Central D1- and D2-receptor occupancy during antipsychotic drug treatmentF A Wiesel, L Farde, A L Nordström, et al.
Brain Research|June 16, 1978
Studies on dopamine turnover in ovariectomized or hypophysectomized female rats. Effects of 17 beta-estradiol benzoate, ethynodioldiacetate and ovine prolactinF A Wiesel, K Fuxe, T Hökfelt, et al.
Psychopharmacology|February 1, 1994
An open clinical and biochemical study of ritanserin in acute patients with schizophreniaF A Wiesel, A L Nordström, L Farde, et al.
Acta Psychiatrica Scandinavica|June 1, 1982
Computed tomography of the brain in patients with acute psychosis and in healthy volunteersH Nybäck, F A Wiesel, B M Berggren, et al.
Neuroreport|September 8, 1994
Characterization of dopamine receptor binding sites in the subthalamic nucleusA E Johnson, H Coirini, L Källström, et al.
Synapse (New York, N.Y.)|October 19, 1999
Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidolJ Yu, L Källström, F A Wiesel, et al.
Brain Research. Molecular Brain Research|December 5, 1997
Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptorsH Coirini, L Källström, F A Wiesel, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Life Sciences|December 21, 1987
Decreased tyrosine transport in fibroblasts from schizophrenic patientsL Hagenfeldt, N Venizelos, L Bjerkenstedt, et al.
Psychopharmacology|January 1, 1989
D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neurolepticsL Farde, F A Wiesel, A L Nordström, et al.
Lancet (London, England)|January 5, 1980
Increased content of immunoreactive prostaglandin E in cerebrospinal fluid of patients with schizophreniaA A Mathé, G Sedvall, F A Wiesel, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1990
Central D1- and D2-receptor occupancy during antipsychotic drug treatmentF A Wiesel, L Farde, A L Nordström, et al.
Brain Research|June 16, 1978
Studies on dopamine turnover in ovariectomized or hypophysectomized female rats. Effects of 17 beta-estradiol benzoate, ethynodioldiacetate and ovine prolactinF A Wiesel, K Fuxe, T Hökfelt, et al.
Psychopharmacology|February 1, 1994
An open clinical and biochemical study of ritanserin in acute patients with schizophreniaF A Wiesel, A L Nordström, L Farde, et al.
Acta Psychiatrica Scandinavica|June 1, 1982
Computed tomography of the brain in patients with acute psychosis and in healthy volunteersH Nybäck, F A Wiesel, B M Berggren, et al.
Neuroreport|September 8, 1994
Characterization of dopamine receptor binding sites in the subthalamic nucleusA E Johnson, H Coirini, L Källström, et al.
Synapse (New York, N.Y.)|October 19, 1999
Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidolJ Yu, L Källström, F A Wiesel, et al.
Brain Research. Molecular Brain Research|December 5, 1997
Modulation of basal ganglia neurotransmission by the classical antipsychotic fluphenazine is due in part to the blockade of dopamine D1-receptorsH Coirini, L Källström, F A Wiesel, et al.
Pageof 9